GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Equity-to-Asset

IM Cannabis (XCNQ:IMCC) Equity-to-Asset : 0.30 (As of Dec. 2023)


View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. IM Cannabis's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$14.5 Mil. IM Cannabis's Total Assets for the quarter that ended in Dec. 2023 was C$48.8 Mil. Therefore, IM Cannabis's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.30.

The historical rank and industry rank for IM Cannabis's Equity-to-Asset or its related term are showing as below:

XCNQ:IMCC' s Equity-to-Asset Range Over the Past 10 Years
Min: -5.81   Med: 0.37   Max: 1261.33
Current: 0.3

During the past 13 years, the highest Equity to Asset Ratio of IM Cannabis was 1261.33. The lowest was -5.81. And the median was 0.37.

XCNQ:IMCC's Equity-to-Asset is ranked worse than
80.88% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs XCNQ:IMCC: 0.30

IM Cannabis Equity-to-Asset Historical Data

The historical data trend for IM Cannabis's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Equity-to-Asset Chart

IM Cannabis Annual Data
Trend Apr13 Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.81 0.29 0.70 0.37 0.30

IM Cannabis Quarterly Data
Jan19 Apr19 Jul19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.42 0.38 0.37 0.30

Competitive Comparison of IM Cannabis's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Equity-to-Asset falls into.



IM Cannabis Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

IM Cannabis's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=14.469/48.813
=0.30

IM Cannabis's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=14.469/48.813
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IM Cannabis  (XCNQ:IMCC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


IM Cannabis Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis (XCNQ:IMCC) Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.